How Does Cross-Border M&A Due Diligence Protect Buyers from Hidden Liabilities?

Antitrust filings trigger mandatory waiting periods and agency review cycles that can delay closing for months or require structural concessions, such as divestitures or behavioral remedies, to obtain clearance. In the United States, filings under the Hart-Scott-Rodino (HSR) Act impose a 30-day initial review period, extendable to 30 additional days if the Federal Trade Commission or Department of Justice requests a second request. Foreign agencies, including the European Commission and national competition authorities, operate on separate timelines and substantive standards. Your company must budget for parallel filings, expert economic analysis, and potential renegotiation of deal terms if agencies signal competitive harm. Failure to obtain required approvals before closing can expose you to unwinding liability and regulatory fines.

Foreign investment screening by national security agencies can block or condition acquisitions of sensitive assets, including defense contractors, critical infrastructure, telecommunications, and technology firms. The Committee on Foreign Investment in the United States (CFIUS) reviews transactions involving foreign acquirers and U.S. .usinesses in designated sectors, with authority to suspend, condition, or unwind deals on national security grounds. Many countries operate equivalent screening regimes with opaque criteria and unpredictable timelines. Your company must file mandatory notifications early, prepare detailed mitigation proposals, and accept the risk that screening agencies may impose operational controls or data restrictions that reduce deal value. Proceeding without clearance exposes you to forced divestiture and civil penalties.

Legal due diligence examines corporate organization and governance, material contracts, intellectual property ownership, litigation and regulatory compliance, real property and environmental status, and employment matters across all jurisdictions where the target operates. Your team must review corporate bylaws, shareholder registers, board minutes, and capitalization tables to verify clean title and authority to sell. Material contracts require clause-by-clause review to identify change-of-control provisions, consent requirements, termination triggers, and assignment restrictions that may block key relationships post-closing. Intellectual property diligence confirms ownership of patents, trademarks, copyrights, and trade secrets; unregistered or contested IP can cripple product lines. Litigation and regulatory compliance review must capture pending disputes, regulatory investigations, compliance violations, environmental liabilities, and sanctions exposure. Employment diligence covers union agreements, pension obligations, severance commitments, and labor law compliance in each jurisdiction.

The purchase agreement allocates risk through representations and warranties, indemnification provisions, escrow arrangements, and survival periods that define which party bears the cost of undisclosed liabilities discovered after closing. Your company should negotiate broad seller representations covering legal compliance, regulatory status, contract validity, and absence of undisclosed liabilities. Indemnification provisions establish thresholds, caps, and baskets that determine when the seller must reimburse your company for breaches. Escrow holdback, typically 10 to 15 percent of purchase price, creates a fund to satisfy indemnification claims during the survival period, usually 12 to 24 months post-closing. Survival periods should be longer for tax, environmental, and intellectual property matters, which often reveal defects years after closing.

Transfer pricing disputes occur when revenue authorities in the acquirer's country or the target's country challenge the purchase price, the allocation of purchase price to intangible assets, or intercompany pricing for post-closing services and financing. Revenue authorities apply arm's length standards, requiring that transfer prices reflect what unrelated parties would have negotiated. Your company must prepare transfer pricing documentation supporting the purchase price before filing tax returns; absent contemporaneous documentation, you face penalties, interest, and the burden of proving reasonableness to the tax authority. Double taxation occurs when both the acquirer's and target's home countries claim tax on the same income; tax treaties may provide relief, but relief requires filing in both jurisdictions and resolving disagreements through mutual agreement procedures that can take years.

To recover under an indemnification provision, your company must prove that the seller made a representation or warranty, that representation was false or breached, the breach was not disclosed in the purchase agreement schedules, your company suffered loss as a result, and the loss exceeds the indemnification threshold and basket. Your company must provide written notice of the claim within the survival period, specifying the breached representation, the factual basis, and the quantified loss. Many purchase agreements require that your company mitigate damages by taking reasonable steps to reduce loss; failure to mitigate can reduce recovery. Disputes over whether a breach occurred, whether it was disclosed, and the amount of loss frequently end in arbitration or litigation, requiring your company to produce contemporaneous records, expert testimony, and detailed damage calculations.

Your company should establish a post-closing claims process that identifies potential breaches, documents discovery, calculates loss, and issues timely written notice before the survival period expires. A New York-based acquirer may file indemnification claims in the forum specified in the purchase agreement, which often requires arbitration or mediation before litigation; procedural delays in notice or filing can waive the claim entirely. Your company must segregate post-closing discovery from pre-closing due diligence records to establish what was unknown at closing versus what was disclosed in schedules. Retain all communications with the target, third parties, and advisors that evidence the state of knowledge at closing. Engage accounting and tax experts to quantify loss within 90 days of discovery, as delay weakens credibility and may trigger the survival period to expire before you file notice. Document mitigation efforts, such as steps taken to remediate regulatory violations or renegotiate contracts, to demonstrate that you acted reasonably to limit exposure.